Ask AI

Transforming Lymphoma Management: Practical Integration of CAR T‑Cell Therapies for Improved Outcomes

Enhance your knowledge of CAR T-cell therapies currently used to manage relapsed or refractory B-cell non-Hodgkin lymphoma to select appropriate candidates and formulate evidence-based strategies to improve patient outcomes through an expert-written ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides. 

Share

Program Content

Activities

SOHO 2026 CAR T Lymphoma
Transforming Lymphoma Management: Practical Integration of CAR T-Cell Therapies for Improved Outcomes
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 09, 2026

Activities

CAR T Cell Therapies for Improved Outcomes
Transforming Lymphoma Management: Practical Integration of CAR T Cell Therapies for Improved Outcomes
Video
Congratulations: You achieved a completion on 04/09/2022

Released: October 12, 2026

Expires: April 11, 2027

Activities

Expert Office Hours CAR T Lymphoma
ClinicalThought Expert Office Hours Forum: Transforming Lymphoma With CAR T-cell Therapy
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb